THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE

Abstract

15th Congress of the European-Federation-of-Neurological-Societies (EFNS), Budapest, HUNGARY, SEP 10-13, 2011